4-[2-Methyl-7-(2,4,6-trimethyl-phenyl)-2H-indazol-3-yl]-heptan-4-ol → 2-Methyl-7-(2,4,6-trimethyl-phenyl)-2H-indazole

HRID 1350537

반응식

HRID 1350537 반응식
Cl.[CH3:2][N:3]1[C:11](C(CCC)=CCC)=[C:10]2[C:5]([C:6]([C:19]3[C:24]([CH3:25])=[CH:23][C:22]([CH3:26])=[CH:21][C:20]=3[CH3:27])=[CH:7][CH:8]=[CH:9]2)=[N:4]1.CN1C(C(O)(CCC)CCC)=C2C(C(C3C(C)=CC(C)=CC=3C)=CC=C2)=N1>>[CH3:2][N:3]1[CH:11]=[C:10]2[C:5]([C:6]([C:19]3[C:24]([CH3:25])=[CH:23][C:22]([CH3:26])=[CH:21][C:20]=3[CH3:27])=[CH:7][CH:8]=[CH:9]2)=[N:4]1

참가 물질

3

실험 절차

2-Methyl-3-(1-propyl-but-1-enyl)-7-(2,4,6-trimethyl-phenyl)-2H-indazole Hydrochloride (Ib or 6b Scheme 1)—Prepared from 4-[2-Methyl-7-(2,4,6-trimethyl-phenyl)-2H-indazol-3-yl]-heptan-4-ol (5b) using the procedure in step 8 of Example 1.

출처 및 근거

ORD 기록
ord-f7595f8d7cf949c4a50826b082165e21
출처 데이터셋
uspto-grants-2007_05
특허 번호
US07214699B2

연결된 노트

불러오는 중…